JAK/STAT signaling cascades provide a relative simple and direct connection between ligand binding on the cell surface and gene transcription in the nucleus. These pathways mediate the response to a diverse group of polypeptide ligands which regulate cell growth, differentiation and effector function. One of the best characterized JAK/STAT signaling cascades is the pathway stimulated by interferon- alpha (IFNalpha). Extensive studies of this signal transduction cascade by a number of laboratories has provided a basic understanding of the initial molecular events regulating IFNalpha-induced gene transcription and has established a paradigm for studying other JAK-STAT pathways, as well. During the previous term of this grant, we have explored the molecular interactions between the various components in this cascade: the Tyk2 tyrosine kinase, the IFNaR1 receptor subunit, and the Stat1 and Stat2 transcription factors. In particular, we have: i) identified and characterized the Tyk2 kinase-IFNaR1 receptor complex; ii) identified and characterized the ligand-inducible Phosphotyrosine docking site on IFNaR1 which recruits the SH2 domain of Stat2; and iii) partially reconstituted the IFNalpha signaling pathway using chimeric receptors. Many details of the molecular interactions controlling this pathway, however, remain unknown, including which parts of the Tyk2 kinase are required for the interaction with IFNaR1, how the Stat2-Stat1 heterodimer is released from the receptor, the role of the distal portion of the IFNaR1 subunit and which specific molecules are involved in the negative regulation of this pathway.
Four specific aims are proposed to investigate some of the these details: 1. Identify the residues in Tyk2 required for interaction with the IFNaR1 receptor subunit. 2. Define the mechanism of Stat1-Stat2 heterodimer formation. 3. Identify additional IFNaR1-interacting proteins which regulate IFNalpha signaling. 4. Investigate the role of CIS proteins in the regulation of the Tyk2 kinase and/or the IFNaR1 subunit.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA056862-12
Application #
6624664
Study Section
Pathology B Study Section (PTHB)
Program Officer
Mufson, R Allan
Project Start
1992-04-10
Project End
2004-11-30
Budget Start
2002-12-01
Budget End
2003-11-30
Support Year
12
Fiscal Year
2003
Total Cost
$261,864
Indirect Cost
Name
University of California Irvine
Department
Pathology
Type
Schools of Medicine
DUNS #
046705849
City
Irvine
State
CA
Country
United States
Zip Code
92697
El Fiky, Ashraf; Pioli, Pete; Azam, Arif et al. (2008) Nuclear transit of the intracellular domain of the interferon receptor subunit IFNaR2 requires Stat2 and Irf9. Cell Signal 20:1400-8
El Fiky, Ashraf; Arch, Allison E; Krolewski, John J (2005) Intracellular domain of the IFNaR2 interferon receptor subunit mediates transcription via Stat2. J Cell Physiol 204:567-73
Saleh, Abu Z M; Greenman, Kevin L; Billings, Susan et al. (2005) Binding of madindoline A to the extracellular domain of gp130. Biochemistry 44:10822-7
Krolewski, John J (2005) Cytokine and growth factor receptors in the nucleus: what's up with that? J Cell Biochem 95:478-87
Saleh, Abu Z M; Fang, Aaron T; Arch, Allison E et al. (2004) Regulated proteolysis of the IFNaR2 subunit of the interferon-alpha receptor. Oncogene 23:7076-86
Nguyen, Vinh-Phuc; Saleh, Abu Z M; Arch, Allison E et al. (2002) Stat2 binding to the interferon-alpha receptor 2 subunit is not required for interferon-alpha signaling. J Biol Chem 277:9713-21
Saleh, Abu Z M; Nguyen, Vinh-Phuc; Krolewski, John J (2002) Affinity of Stat2 for the subunits of the interferon alpha receptor. Biochemistry 41:11261-8
Nastiuk, K L; Mansukhani, M; Terry, M B et al. (1999) Common mutations in BRCA1 and BRCA2 do not contribute to early prostate cancer in Jewish men. Prostate 40:172-7
Krishnan, K; Singh, B; Krolewski, J J (1998) Identification of amino acid residues critical for the Src-homology 2 domain-dependent docking of Stat2 to the interferon alpha receptor. J Biol Chem 273:19495-501
Singh, B; Ittmann, M M; Krolewski, J J (1998) Sporadic breast cancers exhibit loss of heterozygosity on chromosome segment 10q23 close to the Cowden disease locus. Genes Chromosomes Cancer 21:166-71

Showing the most recent 10 out of 21 publications